title: Effect of β-cyclodextrin derivatives on the diosgenin absorption in Caco-2 cell monolayer and rats.
abstract: Orally administrated diosgenin, a steroidal saponin found in the roots of Dioscorea villosa, improves reduced skin thickness in ovariectomized mice, and plays an important role in the treatment of hyperlipidemia. Diosgenin has been noticed as an active element in cosmeceutical and dietary supplements. We have already elucidated that the absolute oral bioavailability of diosgenin is very low; however, a high skin distribution of diosgenin was also observed. The aim of the present study was to examine and compare the effects of β-cyclodextrin (β-CD) and 3 kinds of its derivatives such as hydroxypropyl β-CD on the diosgenin permeability using a Caco-2 model and rat jejunal perfusion. These derivatives of β-CD greatly improved the low solubility of diosgenin. No significant increase was observed in the lactate dehydrogenase leakage from Caco-2 cell, while a slight decrease was found on the transepithelial electrical resistance by diosgenin and β-CD derivatives. However, β-CD derivatives, especially hydroxyethyl β-CD and hydroxypropyl β-CD, markedly enhanced diosgenin permeability across the Caco-2 monolayer and rat jejunum. The bioavailability of diosgenin in the presence of β-CD derivatives were about 4 to 11 fold higher than diosgenin suspension. The mechanisms of these enhancement effects may be due to improvements in solubility and tight junction opening.
authors.affiliation: Faculty of Pharmaceutical Sciences, Josai University.
authors.forename: Masaki
authors.initials: M
authors.lastname: Okawara
authors.forename: Yoshihiro
authors.initials: Y
authors.lastname: Tokudome
authors.forename: Hiroaki
authors.initials: H
authors.lastname: Todo
authors.forename: Kenji
authors.initials: K
authors.lastname: Sugibayashi
authors.forename: Fumie
authors.initials: F
authors.lastname: Hashimoto
mesh_terms: D000073738:2-Hydroxypropyl-beta-cyclodextrin; D000042:Absorption; D000284:Administration, Oral; D000818:Animals; D001682:Biological Availability; D018938:Caco-2 Cells; D003505:Cyclodextrins / Q000494:pharmacology; D027742:Dioscorea / Q000737:chemistry*; D004144:Diosgenin / Q000378:metabolism*; D006801:Humans; D007413:Intestinal Mucosa / Q000187:drug effects* / Q000378:metabolism; D007583:Jejunum / Q000187:drug effects* / Q000378:metabolism; D008297:Male; D010539:Permeability; D010936:Plant Extracts / Q000494:pharmacology*; D051381:Rats; D017208:Rats, Wistar; D012995:Solubility; D019108:Tight Junctions / Q000187:drug effects; D047392:beta-Cyclodextrins / Q000494:pharmacology*
chemical_list: D003505:Cyclodextrins; D010936:Plant Extracts; D047392:beta-Cyclodextrins; D000073738:2-Hydroxypropyl-beta-cyclodextrin; D004144:Diosgenin